Eczema Clinical Research Studies
Interested in joining a clinical research trial?
Atopic dermatitis, or eczema, is the most common chronic inflammatory, pruritic skin disease. It causes intense itching and scratching which leads to a severe rash. Recent eczema studies have given researchers more information about this disease, which is leading to a better understanding of the ailment and new treatment options. There are currently a variety of eczema studies available at our center for patients with mild to severe atopic dermatitis. These studies include treatments such as biologics (complicated molecules that are manufactured within a living organism), a topical gel, and an oral medication designed to help decrease extremely itchy skin involved with eczema. These study medications are at the forefront of current medicine and are provided at absolutely no cost, and with no insurance needed. You may also be reimbursed for your time and travel and will receive care from a physician affiliated with the Clinical Research Center of Alabama.
Biologic Injection Study
Ages 6 months-6 years
A phase 2/3 study investigating the pharmacokinetics, safety, and efficacy of Dupilumab in patients aged ≥6 months to < 6years with severe atopic dermatitis.
ORAL MEDICATION STUDY
The main purpose of this study is to see if difelikeafalin oral tablets (taken by mouth) can reduce the intensity of itching and whether it is well tolerated in subjects with atopic dermatitis and moderate to severe pruritus. Atopic dermatitis is commonly known as eczema, pruritus is commonly known as itchy skin.
Oral Medication - Add-On Therapy
The purpose of this study is to compare the effectiveness and safety of upadacitinib (ABT-494) to placebo (pill without any active substance that looks like upadacitinib) in combination with topical corticosteroids for adolescents (12-17 years of age) with moderate to severe atopic dermatitis (AD).
The purpose of this study is to evaluate the effect of an investigational drug called Tradipitant on symptoms associated with atopic dermatitis with atopic dermatitis and to assess the safety of Tradipitant.
The purpose of this study is to evaluate the safety and effectiveness of Delgocitinib cream on adult patients with moderate to severe atopic dermatitis.
Biological Injection Study
The main purpose of this study is to determine how well different doses of REGN3500 work in treating moderate-to-severe eczema and if REGN3500 is safe.
The purpose of this study is to compare how effective and well-tolerated by the body the study drug is when given as capsules (2g) compared to placebo.
Oral Medication Compared To Dupilumab (Dupixent)
Ages 12-75 (males) / 19-75 (females)
Biologic Injection Study
Biologic Injection Survey
Become a Participant in our Eczema Studies
If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.